AustralianSuper Pty Ltd Grows Stock Holdings in HCA Healthcare, Inc. $HCA

AustralianSuper Pty Ltd boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 201.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 142,372 shares of the company’s stock after buying an additional 95,181 shares during the period. AustralianSuper Pty Ltd’s holdings in HCA Healthcare were worth $66,468,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of HCA. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $1,021,000. NewEdge Advisors LLC lifted its position in HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares in the last quarter. Sivia Capital Partners LLC increased its holdings in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. Jump Financial LLC bought a new position in shares of HCA Healthcare during the second quarter valued at $2,073,000. Finally, Sei Investments Co. raised its position in HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after buying an additional 49,214 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This represents a 16.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.50% of the stock is currently owned by insiders.

HCA Healthcare Trading Up 1.3%

NYSE HCA opened at $432.99 on Friday. The stock has a market cap of $96.06 billion, a price-to-earnings ratio of 14.89, a PEG ratio of 1.36 and a beta of 1.18. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The company’s 50 day moving average is $481.18 and its two-hundred day moving average is $486.29.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s revenue was up 4.3% on a year-over-year basis. During the same period last year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on HCA shares. Wall Street Zen lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. The Goldman Sachs Group lifted their target price on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Argus lowered their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Finally, Leerink Partners cut their price target on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $517.82.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.